We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor

This study has been terminated.
(The study was terminated early following assessment of the two co-primary endpoints showing the lack of efficacy of the study product.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00796445
First Posted: November 24, 2008
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
GlaxoSmithKline
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2016
  Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: November 16, 2012